Ausgabe 3/2008
Inhalt (16 Artikel)
Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis
P. Vestergaard, N. R. Jorgensen, P. Schwarz, L. Mosekilde
Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system
P. Clark, F. Carlos, C. Barrera, J. Guzman, A. Maetzel, P. Lavielle, E. Ramirez, V. Robinson, R. Rodriguez-Cabrera, J. Tamayo, P. Tugwell
Age trends in proximal femur geometry in men: variation by race and ethnicity
T. G. Travison, T. J. Beck, G. R. Esche, A. B. Araujo, J. B. McKinlay
Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa
A. L. Haagensen, H. A. Feldman, J. Ringelheim, C. M. Gordon
Impact of maternal veiling during pregnancy and socioeconomic status on offspring’s musculoskeletal health
M. Nabulsi, Z. Mahfoud, J. Maalouf, A. Arabi, G. E.-H. Fuleihan
A whole genome linkage scan for QTLs underlying peak bone mineral density
F. Zhang, P. Xiao, F. Yang, H. Shen, D.-H. Xiong, H.-Y. Deng, C. J. Papasian, B. M. Drees, J. J. Hamilton, R. R. Recker, H.-W. Deng
Interaction between playing golf and HRT on vertebral bone properties in post-menopausal women measured by QCT
P. Eser, J. Cook, J. Black, R. Iles, R. M. Daly, R. Ptasznik, S. L. Bass
The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer
Y. Yamada, S. Takahashi, T. Fujimura, H. Nishimatsu, A. Ishikawa, H. Kume, K. Tomita, T. Takeuchi, T. Kitamura
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
M. R. Allen, E. Gineyts, D. J. Leeming, D. B. Burr, P. D. Delmas
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies
I. Byrjalsen, D. J. Leeming, P. Qvist, C. Christiansen, M. A. Karsdal
Adherence to alendronate in male veterans
K. E. Hansen, E. D. Swenson, B. Baltz, A. A. Schuna, A. N. Jones, M. E. Elliott
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial
C. C. Mok, K. H. Tong, C. H. To, Y. P. Siu, K. M. Ma
Fracture risk remains reduced one year after discontinuation of risedronate
N. B. Watts, A. Chines, W. P. Olszynski, C. D. McKeever, M. R. McClung, X. Zhou, A. Grauer
Characteristics of patients initiating teriparatide for the treatment of osteoporosis
S. A. Foster, K. A. Foley, E. S. Meadows, J. A. Johnston, S. Wang, G. M. Pohl, S. R. Long
Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-year follow-up
F. E. McKiernan
Postmenopausal bone loss in human skeletal remains of a historical population of southeastern France
B. Mafart, J. Fulpin, P. Y. Chouc